Study S000820

Effect of Lixisenatide on Glucagon Secretion During Hypoglycemia in Patients With Insulin-treated Type 2 Diabetes

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT02020629
Study type: INTERVENTIONAL
Phase: PHASE4
Masking: NONE
Status: COMPLETED
Enrollment: 18
Start: 2013-12
Primary completion: 2014-08
Lead sponsor: Lund University
Conditions: Type 2 Diabetes
Interventions: DRUG:Lixisenatide
Results posted: FALSE
Secondary identifiers: EUDRACT_NUMBER:2012-004959-36

Registered primary outcomes

Glucagon response to hypoglycemia [30 min]

Linked records (1)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0014167	Effect of the GLP-1 Receptor Agonist Lixisenatide on Counterregulatory Responses to Hypoglycemia in Subjects With Insulin-Treated Type 2 Diabetes. Farngren J, Diabetes care	2016	Randomized trial	PMID 26537183 DOI	cites ClinicalTrials.gov:NCT02020629; registry reference DERIVED:26537183